EYEBIOTECH LIMITED
Company number 13503296 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-07-09
- Registered office
- 120 Moorgate, London, England, EC2M 6UR
- Postcode
- EC2M 6UR
- Capital
- 12 GBP
- Accounts category
- Full
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-07-08
- Next due by
- 2027-07-22
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 11 resigned
Benjamin Paul LUCAS
Director
Martin Ian ROGERS
Director
Group structure
Controlled by Merck & Co., Inc. (79546100) — since 2024-07-11
From persons-with-significant-control filings on the public register.
Contact details
- Website
- eyebiotech.com
Our focus on research for retinal disease treatments Breakdown of the blood-retinal barrier and subsequent vascular leakage are hallmark features of retinal vascular diseases, such as DME and NVAMD, which result in vision loss. Vascular leakage is a modifiable feature of these diseases. Our scientists are exploring targets such as the Wingless-related integration site (Wnt) […]